←
CML AdvocatesNetwork7,559 posts
CML AdvocatesNetwork avatar

CML AdvocatesNetwork

@cmlnet

CML Advocates Network: Network of 128 chronic myeloid leukemia patient groups in 93 countries. #CML #Leukemia #CureCML #PatientAdvocacy

◷ Joined January 2011▧ 2,366 Photos and videos
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 15

Empowering Patients Through Digital Health Literacy Joining us virtually at CML Horizons 2026, Felipe Tapia from Maxi-Vida Chile presents Maxi-Vida Digital CML Health Literacy. Access to clear, reliable and understandable health information is essential for empowering people living with CML. Digital education initiatives can help patient organisations reach wider communities, strengthen patient knowledge and support informed conversations about care. #CMLHZ26 #HealthLiteracy #DigitalHealth #PatientEducation #CMLAdvocatesNetwork

Post attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 15

Improving Quality of Life for People Living with CML At CML Horizons 2026, Jiyeon Baek from the Korea Blood Disease & Cancer Association presents the CML Quality of Life Elevation Campaign. Living with CML is about more than treatment response. Emotional wellbeing, everyday challenges and long-term quality of life are equally important. This initiative highlights the valuable role patient organisations play in raising awareness of patients' needs and advocating for better support. Because quality of life matters. #CMLHZ26 #QualityOfLife #PatientAdvocacy #CMLAdvocatesNetwork #CML

Post attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 15

Our Goal: Collaboration and Joint Decision-Making At CML Horizons 2026, Jenny Borst from Hematon, the Netherlands, shares an advocacy initiative focused on strengthening collaboration and joint decision-making. Meaningful patient involvement starts with open communication, mutual understanding and partnerships between patients and healthcare professionals. An important reminder that patients should not only receive care but also have an active voice in decisions that affect their lives. #CMLHZ26 #SharedDecisionMaking #PatientVoice #CMLAdvocatesNetwork #CML

Post attachmentPost attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 15

Supporting Family Planning for People Living with CML Sukhrob Saliev from the Uzbekistan CML Patients League presents Data-Driven Family Planning for CML Patients. Family planning is an important part of life for many people living with CML, and access to reliable information and appropriate support can help patients make informed decisions about their future. This presentation highlights an advocacy initiative focused on bringing data and patient needs together. #CMLHZ26 #CMLAdvocatesNetwork #FamilyPlanning #PatientAdvocacy #CML

Post attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 15

Day 3 od #cmlhz26!! Finding Solutions to Treatment Access Challenges Linda Sitorus and Susina Sukardi from the Indonesia CML & GIST Community share their experiences in addressing treatment access challenges. Despite remarkable progress in CML treatment, patients in many parts of the world continue to face barriers to accessing the care they need. Their presentation brings an important advocacy perspective to the discussion, highlighting the value of sharing experiences and working towards practical solutions. #CMLHZ26 #AccessToTreatment #HealthEquity #PatientAdvocacy #CMLAdvocatesNetwork

Post attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 14

Drug Interactions and Safety Considerations in CML Treatment At CML Horizons 2026, Rachel Giles, joining us virtually, addresses an important aspect of long-term CML management: understanding drug interactions and treatment safety. For people taking TKIs, awareness of possible interactions with other medications and substances is essential. This session reinforces the importance of patient education, regular communication with healthcare professionals and informed treatment management. #CMLHZ26 #DrugInteractions #CMLTreatment #PatientSafety #CMLAdvocatesNetwork

Post attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 14

Staying Safe on TKI Treatment: Prevention, Awareness & Communication Nataliia Lopina explores the importance of treatment safety and effective communication for people living with CML. Understanding potential risks, recognising concerns and maintaining open conversations with healthcare professionals are important aspects of long-term treatment. Empowering patients with knowledge helps them take an active role in their care and communicate confidently with their healthcare teams. #CMLHZ26 #TKISafety #PatientEducation #CMLTreatment #CMLAdvocatesNetwork

Post attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 14

Living with CML: Looking Beyond the Physical Symptoms Mental health and emotional wellbeing are essential parts of the CML patient experience. Lisa Machado, joining us virtually, brings the patient perspective to this important conversation. Living with a chronic condition can affect emotional wellbeing, relationships, everyday life and the way patients think about their future. By recognising these experiences and ensuring that the patient voice is heard, we can advocate for care that addresses the whole person, not only the disease. Because quality of life matters. #CMLHZ26 #MentalHealth #QualityOfLife #PatientVoice #CMLAdvocatesNetwork

Post attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 14

Pregnancy and Fertility in CML: Supporting Patients Through Important Life Decisions At CML Horizons 2026, Prof. Jane Apperley addresses pregnancy and fertility in people living with CML. Family planning can raise important questions about treatment, safety and long-term care. This session highlights the importance of informed discussions between patients and their healthcare teams, ensuring that personal goals and medical considerations are addressed together. Because living with CML is about much more than managing the disease — it is also about planning for the future. #CMLHZ26 #PregnancyAndCML #PatientCentredCare #CMLAdvocatesNetwork #CML

Post attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 14

🔬 Treatment-Free Remission: What Can Biology Tell Us? At CML Horizons 2026, Prof. François-Xavier Mahon explores Biology and Predictors for Treatment-Free Remission and Treatment Response. Understanding the biological factors associated with treatment response and successful treatment-free remission is an important area of CML research. As scientific knowledge continues to advance, these insights may help inform future treatment strategies and more personalised approaches to CML care. #CMLHZ26 #TreatmentFreeRemission #CMLResearch #PersonalisedMedicine #CMLAdvocatesNetwork

Post attachmentPost attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 14

💬 Shared Decision-Making in CML: Two Realities What does shared decision-making look like when patients have different levels of access to treatment options and healthcare resources? At CML Horizons 2026, Joannie Clements and Milica Kuzmanoska facilitate a workshop exploring this important question. The discussion brings together two perspectives: 🩺 Giora Sharf and Prof. Jane Apperley – Shared decision-making in a standard care setting. 🩺 Boris Machavariani and Irina Datikashvili-David – Shared decision-making when treatment choices are limited. Because meaningful patient involvement matters in every healthcare setting, even when the available options differ. #CMLHZ26 #SharedDecisionMaking #PatientVoice #CMLTreatment #CMLAdvocatesNetwork

Post attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 14

🌱 How can we build stronger and more sustainable patient organisations? At CML Horizons 2026, Ana Marjanovic and Catherine Moura lead an interactive workshop on Building Sustainable Patient Organisations. From organisational challenges to long-term planning and collaboration, sustainability is essential for patient groups to continue supporting their communities and making a lasting impact. An opportunity for advocates to exchange experiences, learn from one another and explore practical approaches to strengthening their organisations. #CMLHZ26 #PatientOrganisations #SustainableAdvocacy #CMLAdvocatesNetwork #PatientAdvocacy

Post attachmentPost attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 14

🧬 Could new treatment strategies improve the future of CML care? Prof. Jane Apperley takes the stage once again to discuss Combination Strategies and Improved TKI Formulations. As research continues to evolve, scientists are exploring different approaches to optimise CML treatment, improve tolerability and address remaining challenges. An opportunity for patient advocates to better understand the research directions that could shape future treatment choices. #CMLHZ26 #CMLTreatment #TKIs #CMLResearch #PatientAdvocacy

Post attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 14

💊 New Drugs on the Horizon: What Could Be Next for CML? Prof. Andreas Hochhaus, joining us virtually, explores emerging treatments and new developments in CML research. Continued innovation offers opportunities to address unmet needs and expand future treatment options. For patient advocates, staying informed about the evolving treatment landscape is essential to supporting patients and contributing to meaningful discussions about access and care. #CMLHZ26 #CMLResearch #NewTreatments #CMLAdvocatesNetwork #PatientAdvocacy

Post attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 14

⚖️ Asciminib as First-Line Therapy: Pro or Con? One of today's thought-provoking discussions at CML Horizons 2026 brings together two leading CML experts for a scientific debate. 🎤 Prof. Jane Apperley presents the arguments in favour of asciminib as first-line therapy. 🎤 Prof. François-Xavier Mahon presents the opposing perspective. What factors should influence first-line treatment decisions? How do we balance effectiveness, safety, long-term outcomes and individual patient needs? An important exchange of scientific perspectives to support informed discussions about the evolving CML treatment landscape. #CMLHZ26 #Asciminib #CMLTreatment #SharedDecisionMaking #CMLAdvocatesNetwork

Post attachmentPost attachmentPost attachmentPost attachment
CML AdvocatesNetwork avatar
CML AdvocatesNetwork@cmlnet·Nov 14

Day 2 of CML Horizons 2026 is underway! We are starting the day with an exciting, hands-on workshop: Practical AI for Patient Advocacy, facilitated by Eilon Grouper. Artificial intelligence is opening up new possibilities for patient organisations, from improving communication and developing educational materials to supporting everyday advocacy work. Today's workshop explores how advocates can use AI tools practically, responsibly and effectively to strengthen their impact. A fantastic way to kick off another day of learning, sharing and growing together in Tbilisi! #CMLHZ26 #CMLAdvocatesNetwork #PatientAdvocacy #ArtificialIntelligence #CML

Post attachmentPost attachment